Circle Wealth Management LLC Has $488,000 Stock Holdings in Tempus AI, Inc. $TEM

Circle Wealth Management LLC grew its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 34.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,111 shares of the company’s stock after buying an additional 2,608 shares during the quarter. Circle Wealth Management LLC’s holdings in Tempus AI were worth $488,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. ARK Investment Management LLC grew its holdings in shares of Tempus AI by 35.9% in the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Vanguard Group Inc. grew its holdings in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after acquiring an additional 5,900,668 shares during the last quarter. Nikko Asset Management Americas Inc. grew its holdings in Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after acquiring an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock worth $205,284,000 after acquiring an additional 1,016,384 shares during the last quarter. Finally, Frontier Capital Management Co. LLC grew its holdings in Tempus AI by 236.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company’s stock worth $31,860,000 after acquiring an additional 663,018 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $76.71 on Friday. The company has a market capitalization of $13.33 billion, a price-to-earnings ratio of -64.46 and a beta of 4.98. The firm’s 50 day simple moving average is $63.59 and its 200 day simple moving average is $59.09. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $91.45.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. Tempus AI’s revenue for the quarter was up 89.5% on a year-over-year basis. During the same period last year, the company posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Guggenheim increased their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a “buy” rating in a report on Monday, June 30th. Bank of America increased their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Needham & Company LLC reissued a “buy” rating and set a $70.00 price objective on shares of Tempus AI in a report on Friday, August 8th. Piper Sandler restated a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Finally, Morgan Stanley upped their target price on shares of Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a research report on Tuesday, August 12th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $67.64.

Insiders Place Their Bets

In other Tempus AI news, EVP Erik Phelps sold 3,664 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $273,517.60. Following the sale, the executive vice president directly owned 94,115 shares in the company, valued at approximately $7,025,684.75. This trade represents a 3.75% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Andrew Polovin sold 5,398 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $402,960.70. Following the sale, the executive vice president owned 132,056 shares in the company, valued at $9,857,980.40. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 776,451 shares of company stock worth $53,022,688 over the last ninety days. Company insiders own 27.60% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.